STALICLA SA’s CEO Lynn Durham will be part of the panel at the Neurotech Investing & Partnering Conference taking place on May 1st in Boston, USA. The ‘Targeting Orphan Diseases’ panel which Lynn is a part of, will take place at 3:40pm Tuesday May 1st.
SACHS Biocapital USA Forum taking place on 21st March at the New York Academy of Sciences, USA. We are delighted to announce that CEO Lynn Durham will deliver a presentation showcasing STALICLA’s innovative approach and development pipeline, at 11:20am. In addition, Lynn will also be a part of the of the ‘Renewed Approaches for Neuroscience’ panel, which will be held at 11:45am. The Plenary panel is likely to be a highly anticipated session where Lynn will be discussing the hot topic of advanced therapeutics alongside other biotech and pharmaceutical leaders.
STALICLA selected among the 2018 top 50 start-ups in Switzerland.